Skip to content
healthcare.dev

ELTROMBOPAG

NDC 70771-1925, eltrombopag, tablet, from Zydus Lifesciences Limited.

Product NDC
70771-1925
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216281
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1925 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ELTROMBOPAG OLAMINE12.5 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Increased Megakaryocyte Maturation [PE]; Increased Platelet Production [PE]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; Thrombopoietin Receptor Agonist [EPC]; Thrombopoietin Receptor Agonists [MoA]; UGT1A1 Inhibitors [MoA]; UGT1A3 Inhibitors [MoA]; UGT1A4 Inhibitors [MoA]; UGT1A6 Inhibitors [MoA]; UGT1A9 Inhibitors [MoA]; UGT2B15 Inhibitors [MoA]; UGT2B7 Inhibitors [MoA]

Package NDCNDC-11Package
70771-1925-37077119250330 TABLET in 1 BOTTLE (70771-1925-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ae9a7725-64f8-406d-88e7-e6e01136deae

Use it

Look up 70771-1925 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1925 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1925. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.